Lybrate.com has top trusted Oncologists from across India. You will find Oncologists with more than 29 years of experience on Lybrate.com. Find the best Oncologists online in Hyderabad. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment with Dr. Vindhya Vasini Andra
Treatment of Cancer
Treatment of Breast Cancer
Breast Cancer Surgery Treatment
Treatment of Tumors
Treatment of Testicular Cancer
Treatment of Blood Cancer
Treatment of Brain Tumor
Treatment of Lung Cancer
Treatment of Colon Cancer
Treatment of Cancer Pain
Treatment of Oral Cancer
Treatment of Prostate Cancer
Treatment of Liver Cancer
Treatment of Throat Cancer
Treatment of Gastric Cancer
Treatment of Acute Lymphoblastic Leukemia
Treatment of Lymphoma
Treatment of Cervical Cancer
Submit a review for Dr. Vindhya Vasini AndraYour feedback matters!
Detecting a lump on your breasts can be stressful for any women. Breast cancer is a common type of cancer and is said to affect primarily affect women though 1% of breast cancer cases affect men. Breast cancer can be categorized into different types based on their capability to affect surrounding tissues.
The most common amongst these are:
- Ductal carcinoma in situ
- Invasive ductal carcinoma
- Invasive lobular carcinoma
Breast cancer is caused by mutations of a person’s DNA cells. This could be inherited from one’s parents or acquired by an unhealthy lifestyle. These DNA mutations cause cells in the breast tissue to multiply rapidly and turn cancerous. The risk factors for breast cancer can be categorized as modifiable and non-modifiable.
Modifiable risk factors:
- Excessive alcohol consumption
- Use of combined hormone therapy after menopause
- Lack of exercise
Non-modifiable risk factors:
- Family Medical History
- Personal Medical History
- Atypical hyperplasia
- Early start of menstruation cycle
- Presence of dense breast tissue
- Inherited genetic mutations
As with any other type of cancer, the earlier it is diagnosed, the easier it is to treat. In its early stages, breast cancer is not painful and has negligible symptoms. In most cases, it is detected only by finding a lump on the breast or through a mammography. This lump may also be present in the armpit or above the collar bone. Some of the other symptoms of breast cancer include:
- Nipple inversion
- Discharge from the nipples
- Changes in the colour and texture of skin covering the breast
Breast cancer has five stages beginning from 0 and going up to 4. This is based on the size of the tumour, involvement of lymph nodes and whether or not metastasis has occurred.
- Stage 0: At this stage, the tumour does not affect the lymph nodes and has not metastasized. Thus at this stage, it is noninvasive.
- Stage I: In this case the tumour is smaller than 2 cm in diameter and has not spread to any of the surrounding tissues.
- Stage II: In this stage, the cancerous tumours are still fairly small in size but also affect the surrounding lymph nodes.
- Stage III: These tumours are larger than 5 cm in diameter and involve the lymph nodes to a greater extent.
- Stage IV: This is also known as metastatic breast cancer. In this stage, the cancer cells metastasize to other parts of the body.
Surgery is the most preferred form of treatment for breast cancer. This may be combined with radiation, chemotherapy, targeted therapy or hormone therapy depending on the stage and type of cancer, the patient's overall health, age and personal preferences.
In many patients with brain metastases, the primary therapeutic aim is symptom palliation and maintenance of neurologic function, but in a subgroup, long-term survival is possible. Local control in the brain, and absent or controlled extracranial sites of disease are prerequisites for favorable survival.
Stereotactic radiosurgery (SRS) is a focal, highly precise treatment option with a long track record. Its clinical development and implementation by several pioneering institutions eventually rendered possible cooperative group randomized trials. A systematic review of those studies and other landmark studies was undertaken.
Most clinicians are aware of the potential benefits of SRS such as a short treatment time, a high probability of treated-lesion control and, when adhering to typical dose/volume recommendations, a low normal tissue complication probability.
However, SRS as sole first-line treatment carries a risk of failure in non-treated brain regions, which has resulted in controversy around when to add whole-brain radiotherapy (WBRT). SRS might also be prescribed as salvage treatment in patients relapsing despite previous SRS and/or WBRT. An optimal balance between intracranial control and side effects requires continued research efforts.
In case you have a concern or query you can always consult an expert & get answers to your questions!